Perpetua Medical AB (OSTO:PERP B) Cyclically Adjusted Revenue per Share: kr6.87 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PERP B Perpetua Medical AB OSTO:PERP B
57 GF Score
Price kr3.30
GF Value kr3.64
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Perpetua Medical AB Cyclically Adjusted Revenue per Share?

Perpetua Medical AB OSTO:PERP B -0.30% 57 Cyclically Adjusted Revenue per Share is kr6.87 as of Mar. 2026. GuruFocus rates OSTO:PERP B with a GF Score™ of 57/100 and a GF Value™ of kr3.64 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Perpetua Medical AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr0.585. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr6.87 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Perpetua Medical AB's average Cyclically Adjusted Revenue Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-20), Perpetua Medical AB's current stock price is kr3.30. Perpetua Medical AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr6.87. Perpetua Medical AB's Cyclically Adjusted PS Ratio of today is 0.48.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Perpetua Medical AB was 0.98. The lowest was 0.25. And the median was 0.59.


Perpetua Medical AB  (OSTO:PERP B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Perpetua Medical AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.30/6.87
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Perpetua Medical AB was 0.98. The lowest was 0.25. And the median was 0.59.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Perpetua Medical AB Cyclically Adjusted Revenue per Share Related Terms


Perpetua Medical AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Perpetua Medical AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perpetua Medical AB Cyclically Adjusted Revenue per Share Chart

Perpetua Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 7.43 6.98

Perpetua Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.29 7.19 7.07 6.98 6.87

OSTO:PERP B vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Perpetua Medical AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perpetua Medical AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Perpetua Medical AB's Cyclically Adjusted PS Ratio falls into.


OSTO:PERP B
57GF Score
Perpetua Medical AB OSTO:PERP B
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perpetua Medical AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Perpetua Medical AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.585/133.5600*133.5600
=0.585

Current CPI (Mar. 2026) = 133.5600.

Perpetua Medical AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 0.106 102.022 0.139
201703 0.427 102.022 0.559
201706 2.496 102.752 3.244
201709 0.194 103.279 0.251
201712 1.863 103.793 2.397
201803 0.488 103.962 0.627
201806 0.558 104.875 0.711
201809 0.130 105.679 0.164
201812 2.078 105.912 2.620
201903 0.925 105.886 1.167
201906 4.519 106.742 5.654
201909 0.054 107.214 0.067
201912 0.119 107.766 0.147
202003 0.484 106.563 0.607
202006 1.094 107.498 1.359
202009 0.025 107.635 0.031
202012 1.641 108.296 2.024
202103 3.705 108.360 4.567
202106 1.412 108.928 1.731
202109 2.215 110.338 2.681
202112 4.774 112.486 5.668
202203 2.514 114.825 2.924
202206 5.025 118.384 5.669
202209 4.663 122.296 5.092
202212 1.911 126.365 2.020
202303 5.063 127.042 5.323
202306 1.577 129.407 1.628
202309 0.311 130.224 0.319
202312 0.529 131.912 0.536
202403 0.399 132.205 0.403
202406 0.225 132.716 0.226
202409 0.085 132.304 0.086
202412 0.921 132.987 0.925
202503 0.714 132.825 0.718
202506 0.597 133.699 0.596
202509 0.769 133.480 0.769
202512 1.019 133.390 1.020
202603 0.585 133.560 0.585

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr6.87 mean?
Perpetua Medical AB (OSTO:PERP B) has a Cyclically Adjusted Revenue per Share of kr6.87 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Perpetua Medical AB and its competitors.
Is Perpetua Medical AB's Cyclically Adjusted Revenue per Share too high?
Perpetua Medical AB's current Cyclically Adjusted Revenue per Share is kr6.87. Overall, Perpetua Medical AB has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Perpetua Medical AB's Cyclically Adjusted Revenue per Share of kr6.87 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Perpetua Medical AB and its competitors. Perpetua Medical AB's current Cyclically Adjusted Revenue per Share is kr6.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Perpetua Medical AB (OSTO:PERP B) is currently considered Fairly Valued. The stock's GF Value™ is kr3.64, compared to a current price of kr3.30 — trading 9.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr6.87. Perpetua Medical AB's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Perpetua Medical AB (OSTO:PERP B), the current Cyclically Adjusted Revenue per Share is kr6.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perpetua Medical AB (OSTO:PERP B) Overvalued in 2026?

Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued. The current stock price of kr3.30 is trading 9.3% below its estimated GF Value™ of kr3.64. GuruFocus considers Perpetua Medical AB to be Fairly Valued.

Key valuation signals for OSTO:PERP B:

  • Cyclically Adjusted Revenue per Share: kr6.87
  • GF Value™: kr3.64 vs. price of kr3.30 (9.3% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the OSTO:PERP B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Perpetua Medical AB Business Description

Address Ekeby Bruk 2H, Uppsala, SWE, SE-752 63
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
57GF Score

Get the complete analysis for OSTO:PERP B

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.30
Price
kr3.64
GF Value